WUXI BIO (02269): Miao Jingwen appointed as non-executive director.
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles
Why did Fosun (00656) choose to proactively unload historical "baggage" at this time?
Xpeng (XPEV.US) G6 Super Long-Range Version Listed: 2250 TOPS Computing Power + Second Generation VLA
CITIC SEC: Continues to be optimistic about storage demand exceeding expectations, and supply shortage will continue until the first half of 2027.
Why did Fosun (00656) choose to proactively unload historical "baggage" at this time?
Xpeng (XPEV.US) G6 Super Long-Range Version Listed: 2250 TOPS Computing Power + Second Generation VLA
CITIC SEC: Continues to be optimistic about storage demand exceeding expectations, and supply shortage will continue until the first half of 2027.
RECOMMEND
